Further assessment of viral transfer during the <24 h time points, trans infection, demonstrated that BIT225 treatment resulted in lower levels of HIV-1 transfer from the MDDC to the uninfected CD4+ T cells in the three donors (Fig. 2a). The gene discussed is CD4; the disease is infection.